Stay updated on UCART123v1.2 in AML Relapse/Refractory - Clinical Trial
Sign up to get notified when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.

Latest updates to the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page
- Check4 days agoChange DetectedAdded a consolidated Locations section listing California, Florida, Illinois, Massachusetts, New York, Pennsylvania, and Texas, and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.9%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check40 days agoChange DetectedThe funding/operating status notice was removed from the page. It previously served as a status banner and did not affect the study details.SummaryDifference0.4%

- Check54 days agoChange DetectedAn updated 'Last Update Posted' timestamp and minor layout adjustments are present. Core study details, eligibility criteria, and outcomes remain unchanged.SummaryDifference0.5%

- Check83 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference4%

- Check90 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to UCART123v1.2 in AML Relapse/Refractory - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UCART123v1.2 in AML Relapse/Refractory - Clinical Trial page.